Page 2861

Volaris Inaugurates New Leon/Bajio – Los Angeles Service

0





Volaris Inaugurates New Leon/Bajio – Los Angeles Service


The new route strengthens Volaris’ commitment to uniting friends and family on both sides of the border


MEXICO CITY, June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — Volaris (NYSE: VLRS and BMV: VOLAR), the ultra low cost Mexican airline with the most extensive route network servicing Mexico and the US, announced today their consolidation in Mexico’s Bajio region, with new international services connecting Leon, Guanajuato to Los Angeles, California operating four times a week on Monday, Wednesday, Friday, and Sunday.

Logo – http://photos.prnewswire.com/prnh/20150325/194587LOGO

“This is yet further proof that we are committed to uniting friends and family on both sides of the border at low fares, efficiently and safely,” said Volaris Commercial Director, Holger Blankenstein. “To date we have transported nearly 5 million passengers to and from California, a number that is on the rise given our more than 160 flights per week, to the seven destinations we service in the state.”

Statistics from Pew Hispanic Center inform that there are over 14 million Hispanic residents in California, of which 83% are of Mexican origin. “Now, it is easier for the paisano community to travel to Mexico’s Bajio Region on board one of the youngest fleets in the Americas – this at the lowest, clean and clear fares,” Blankenstein added.

He also informed that the new route becomes the fifth destination operated by Volaris from Leon, Guanajuato, “at this time we are totaling five destinations serviced from Bajio, and of these, three are to the US, reiterating our other goal which is to provide the region with greater domestic and international connectivity,” he concluded.

“We congratulate Volaris for the introduction of new international service to Los Angeles,” said Gina Marie Lindsey, Executive Director at Los Angeles World Airports. “Volaris will be operating from Terminal 2, currently under transformation. Once we’ve completed this construction, the travel experience for Volaris Customers will improve significantly.”

The new service helps consolidate Volaris positioning as the Mexican airline with highest number of routes throughout Mexico and to the US, totaling 140 routes to 61 destinations, of which 20 are to the US and 38 domestic. Since its inauguration, Volaris has transported over 49 million passengers, and of these nearly 7 million have been to the US. This number continues on the rise as a result of more than 220 daily flights.

For those interested in the new service, flight schedules, including dates and times of operation, are announced as follows:

Leon, Guanajuato – Los Angeles, California
(Effective June 8. Monday, Wednesday, Friday and Sunday)

  • Departing Leon, Guanajuato at 8:30hrs., arriving Los Angeles, California at 10:00hrs.
  • Departing Los Angeles, California at 11:20hrs., arriving Leon, Guanajuato at 16:20 hrs.

Launched at an introductory fare of US$139 one-way, taxes included, flights may be booked ahead of time with Volaris’ innovative “Tu Decides” pay-per-service arrangement, whereby Customers select exclusively those services they need for their specific travel needs. Booking is available on all Volaris sales channels, including online (www.volaris.com) our Call Centers in Mexico (01-800-122-8000) and the US (1-866-988-3527), or through any of our authorized travel agencies.

About Volaris

Controladora Vuela Compania de Aviacion, S.A.B. de C.V. (NYSE: VLRS and BMV: VOLAR) is an ultra low cost airline providing point to point services and operating in Mexico, US, Guatemala, and Costa Rica. The ultra low cost highly efficient business model offered by Volaris provides low base fares to develop its market, coupled with outstanding levels of quality services and a wide array of products. Since beginning their operations in March 2006, Volaris has increased its routes from an initial 5 to a current 140 and its fleet from 4 to 53 aircraft. Volaris currently operates over 220 daily flight segments on routes connecting 39 cities in Mexico and 24 cities internationally with Mexico’s most modern airplane fleet. Volaris targets passengers visiting friends and family, price sensitive business travelers, and leisure travelers in Mexico and to select US destinations. Proudly Mexican, Volaris is regarded as one of the new leading companies in the country. Among other recognitions, Volaris has received the prestigious ESR Award for Social Corporate Responsibility for five consecutive years. For more information, please visit: www.volaris.com


beIN SPORTS Delivers Exclusive LIVE Coverage of Copa America 2015 in Chile

0





beIN SPORTS Delivers Exclusive LIVE Coverage of Copa America 2015 in Chile


Watch All 26 Copa America Matches LIVE on beIN SPORTS,


beIN SPORTS en Espanol and beIN CONNECT


MIAMI, June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — This summer, the most anticipated football tournament of 2015 arrives June 11th as beIN SPORTS, the international sports network, kicks off exclusive coverage of the 2015 Copa America Chile.

The 44th edition of the competition kicks off with Chile against Ecuador in Santiago, Chile, on Thursday, June 11, 2015 with the final group matches scheduled for Sunday, June 21. The knockout round begins on Wednesday, June 24 ahead of the final on Saturday, July 4.  All matches can be seen across all beIN SPORTS platforms.

beIN SPORTS will also feature original news, editorial analysis and multimedia elements around Copa America 2015 from studios and reporters in Chile and across the globe. Special guests and contributors such as Ruud Gullit, Christian Vieri, Juan Pablo Angel, Andy Gray, Richards Keys, Francisco ‘Kikin’ Fonseca, Sergio Goycochea, and Tony Meola will break down and preview all the action and news from each match day.

Copa America, first played in 1916, is the oldest national team football tournament in the world and features three of the most decorated teams in the history of soccer:  Argentina, Brazil and Uruguay which amongst them have won 9 of 20 World Cups and 36 of 42 Copa Americas.  Copa America 2015 features 10 teams from South America; Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Paraguay, Peru, Uruguay and Venezuela and two invited teams: Jamaica & Mexico.  The tournament will feature world superstars such as Lionel Messi, Neymar, James Rodriguez, Alexis Sanchez, Edinson Cavani and Rafa Marquez among many others.

All matches starting on June 11th through the Copa America Final on July 4th, will air live and can only be seen on beIN SPORTS and beIN SPORTS en Espanol. All programming on beIN SPORTS CONNECT is offered in HD and is available for broadband-connected PCs, mobile tablets and smart phones.

For more information, please visit Copa America focused websites in English and Spanish. Follow us on Twitter @beINSPORTSUSA and/or @ESbeINSPORTS and like our beIN SPORTS USA Facebook page for breaking news and real-time updates.

About beIN SPORTS USA

beIN SPORTS USA is the international sports network. Launched in 2012, beIN SPORTS is the fastest growing international sports network in the U.S. and is offered on 9 of the largest 10 cable/satellite TV providers in the U.S., as well as other systems across the country.  beIN SPORTS offers viewers premium sports content and entertainment across multiple platforms including TV channels beIN SPORTS and beIN SPORTS en Espanol and live streaming on beIN SPORTS CONNECT. A cornerstone of beIN SPORTS is its unrivaled live soccer coverage, which includes live matches   from La Liga, Serie A, Ligue 1, Russian Premier League, Copa America 2015, and CONMEBOL/CONCACAF World Cup Qualifiers, as well as news and in-depth analysis of all the top leagues from around the world. With beIN SPORTS CONNECT, authenticated subscribers can also enjoy all the exciting action from the two networks and stream live overflow matches offered in HD on your computer, tablet or smart phone. In addition to soccer, beIN SPORTS serves as a haven to fans of motorsports, tennis, rugby, volleyball and boxing, among others.


DDB Latina’s Ideathon: Creativity Seeking To Influence On A Global Problem In 48 Hrs.

0





DDB Latina’s Ideathon: Creativity Seeking To Influence On A Global Problem In 48 Hrs.


MIAMI, June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — The 11th of June of the current year, the 22 offices that comprise the Latin region of DDB Worldwide (US Hispanic + Latin America + Spain) will connect all their talent to look for ideas to help solve the inequality that today’s women face.

Media is invited to join us for a press conference on Friday, June 12 at 1:00 pm at Alma Agency’s Miami-based office, where a group of talented women and leaders from different fields and spokespersons for the cause will be selecting the best idea. Media can also join us on Thursday, June 11 at 11am to cover how local teams from “Alma Agency” work on proposals/ideas. Please contact us at +1 305-793-2495 or email [email protected] for more information and to gain press access.

These offices plan to put aside their normal work hours to generate innovative proposals that will later be presented to a prestigious jury based in the city of Miami. The teams will consist of all departments from the agency, aiming to not only limit ideas to the creative teams, but also include other points of views in areas such as finance, production, accounts, planning, etc.

Among the personalities invited are: Maria Elena Salinas –Anchor from Noticiero Univision, Silvina Moschini –Entrepreneur and Technology Contributing Expert from CNN en Espanol, Leila Cobo –Billboard Executive Director, and Maria Gabriela Hoch –Global Leadership Network Member from the organization Vital Voices, established by Hillary Rodham Clinton, among others.

This initiative will take place every year covering different social issues, in order to demonstrate that creative talent is capable of generating ideas that will help transform the reality of our world.

“Our teams will apply integrated thinking and most of the ideas will have a strong technological component that will demonstrate how interaction between people changes human reality,” shared John Isaza, VP of Planning.

“We live in a world in real time and only a network such as DDB Latina, which understands this new reality, is able to integrate its teams so that in a period of 48 hours influential ideas are created,” said Juan Carlos Ortiz, President and Creative Chairman of DDB Americas.

ABOUT DDB LATINA:

DDB Latina was the first network in integrating the Latin markets around the world (US Hispanic, Latin America & Spain) with the main objective of consolidating and highlighting the creativity, passion, and thinking of the Latin culture to the world.

In response to its vision of “Influencia”, in 2009 DDB Latina evolves its operational model to “Triplas”, where Planners, Creatives and Digitals incorporate their knowledge from the beginning of the strategic thinking and process to produce their Creativity: Ideas that influence.

DDB Latina or the “United” Region with presence in 29 offices in 22 countries, including the Caribbean, it’s part of DDB worldwide (with more than 200 offices in more than 90 countries), both are part of the Omnicom Group Inc. (OMC).

CONTACT:
Angela Henao
[email protected]
PR Director | DDB Latina
2601 South Bayshore Dr. 4th | Coconut Grove Miami FL 33133
O: +1 305.341.2563 | M: +1 305. 793. 2495


CHRIS BROWN ANNOUNCES ONE HELL OF A NITE TOUR

0





CHRIS BROWN ANNOUNCES ONE HELL OF A NITE TOUR

— Kid Ink, Omarion, Fetty Wap & Teyana Taylor To Join 2015 Summer Amphitheatre Tour As Special Guests —

— Tickets On Sale Starting Friday, June 12 at LiveNation.com —


LOS ANGELES, June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — Multi-platinum selling artist Chris Brown today announced a headlining summer amphitheatre tour. Produced by Live Nation and Haymon Events, the ONE HELL OF A NITE TOUR kicks off on August 12 at Sprint Center in Kansas City, Mo. and will take the acclaimed performer to 25 cities throughout the U.S. including shows in Chicago, Detroit, Boston, Miami, Atlanta, Dallas and San Diego. Kid Ink, Omarion, Fetty Wap and Teyana Taylor will join Chris on the summer tour as special guests. A full list of tour dates is below.

Photo – http://photos.prnewswire.com/prnh/20150608/221610

A Citi® cardmember pre-sale begins Tuesday, June 9 through Citi’s Private Pass® Program. For complete pre-sale details, visit www.citiprivatepass.com. Tickets for the general public go on sale starting Friday, June 12 at www.livenation.com.

GRAMMY Award®-winning singer/songwriter Chris Brown made his sixth #1 album entry on the Billboard R&B/Hip-Hop chart with his latest release X (RCAS Records). The album also debuted at #2 on Billboard’s Top Albums chart, marking his sixth album debut within the Top Ten. X sold over 140,000 units in its first week while Spotify streams of the album continue to rise. Earlier this year, Brown released his first collaborate studio album, Fan of a Fan: The Album, with Tyga.  The album debuted in the Top 10 on the Billboard 200. With the continued release of chart-topping albums and singles, there’s no question why the talented Chris remains one of today’s most influential entertainers. 

ONE HELL OF A NITE TOUR

All dates and venues below subject to change.

Wednesday, August 12

Kansas City, MO

Sprint Center

Thursday, August 13

St. Louis, MO

Scottrade Center

Friday, August 14

Chicago, IL

First Midwest Bank Amphitheatre

Saturday, August 15

Indianapolis, IN

Klipsch Music Center

Sunday, August 16

Detroit, MI

DTE Energy Music Theatre

Tuesday, August 18

Cleveland, OH

Blossom Music Center

Wednesday, August 19

Darien Lake, NY

Darien Lake Performing Arts Center (on sale June 13)

Friday, August 21

Camden, NJ

Susquehanna Bank Center (on sale June 19)

Saturday, August 22

Bristow, VA

Jiffy Lube Live

Sunday, August 23

Bridgeport, CT

Webster Bank Arena* (on sale June 19)

Wednesday, August 26

Holmdel, NJ

PNC Bank Arts Center (on sale June 13)

Friday, August 28

Saratoga Springs, NY

Saratoga Performing Arts Center (on sale June 13)

Saturday, August 29

Boston, MA

Xfinity Center

Sunday, August 30

Wantagh, NY

Nikon at Jones Beach Theatre (on sale June 13)

Tuesday, September 1

Birmingham, AL

Oak Mountain Amphitheatre

Thursday, September 3

Miami, FL

American Airlines Arena

Friday, September 4

Tampa, FL

MIDFLORIDA Credit Union Amphitheatre

Saturday, September 5

Atlanta, GA

Aaron’s Amphitheatre at Lakewood

Wednesday, September 9

Austin, TX

Austin360 Amphitheater

Thursday, September 10

Dallas, TX

Gexa Energy Pavilion

Saturday, September 12

Albuquerque, NM

Isleta Amphitheater

Tuesday, September 15

Phoenix, AZ

US Airways Center

Thursday, September 17

San Diego, CA

Sleep Train Amphitheatre

Friday, September 18

Anaheim, CA

Honda Center

Saturday, September 19

Concord, CA

Concord Pavilion* (on sale June 19)

* – Citi® cardmember pre-sale starts June 16

About Live Nation Entertainment
Live Nation Entertainment (NYSE: LYV) is the world’s leading live entertainment company comprised of global market leaders: Ticketmaster, Live Nation Concerts, Live Nation Media & Sponsorship and Artist Nation Management. For additional information, visit www.livenationentertainment.com.

Follow us @twitter.com/LiveNationInc

 


GLP-1 Alters How the Brain Responds to Food

0





GLP-1 Alters How the Brain Responds to Food


BOSTON, June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — Gut hormone-based medications used to treat diabetes, such as GLP-1 receptor agonists, have also been shown to reduce body weight. Researchers have been working to understand how. This study, presented today at the American Diabetes Association’s 75th Scientific Sessions, sheds light on how GLP-1 receptor agonists alter the brain’s response to food, possibly reducing cravings and increasing satisfaction while eating.

Logo – http://photos.prnewswire.com/prnh/20141105/156803LOGO

Previous studies have shown that the brains of obese people have a greater response to pictures of food than those of lean people, and a reduced reward response during the consumption of food, which may lead to overeating. Researchers in Amsterdam tested the hypothesis that the GLP-1 receptor agonist exenatide – a medication which mimics the effects of natural GLP-1 by binding to the GLP-1 receptor – was helping patients with type 2 diabetes lose weight by altering the brain’s response to food consumption and decreasing appetite.

“When you eat, there are several hormones released. GLP-1 is one of them,” explained Liselotte van Bloemendaal, MD, a PhD student at the Diabetes Center, VU University Medical Center in Amsterdam. “These hormones relay information to the central nervous system about nutritional status to regulate appetite. Using functional MRIs (which measure brain activity by detecting changes in blood flow), we looked at the reward centers in the brains of obese individuals with and without type 2 diabetes and measured the response to the anticipation of and drinking of chocolate milk while being given GLP-1 receptor agonist intravenously versus placebo. We found that GLP-1 receptor activation decreased anticipatory food reward, which may reduce cravings, and increased the feeling of food reward during consumption, which may reduce overeating.”

“Given the dramatic, global rise in the prevalence of obesity, further insights into the mechanisms by which these reward centers are activated are needed,” she said, adding that one avenue that merits further investigation would be to study whether adding a second hormone, such as glucagon, to GLP-1 receptor agonist treatment could further increase weight loss. In addition, Bloemendaal is interested in determining if GLP-1 receptor agonists can alter cravings for drugs, alcohol and nicotine in humans, offering a possible therapeutic target for substance abuse disorders.  The U.S. Food and Drug Administration recently approved the first GLP-1 agonist for the treatment of obesity in the United States.

The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (800-342-2383) or visit diabetes.org. Information from both these sources is available in English and Spanish.


Can Not Having Enough to Eat Lead to Poor Diabetes Management? Study Finds Food Insecurity Affects Glycemic Control and Vegetable Consumption in Latinos

0





Can Not Having Enough to Eat Lead to Poor Diabetes Management? Study Finds Food Insecurity Affects Glycemic Control and Vegetable Consumption in Latinos

Study Suggests New Factor to Be Considered in Diabetes Management


BOSTON, June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — Latinos who worry about having enough food to eat – so-called food insecurity – report having a poorer diet and exhibit worse glycemic control than those who aren’t worried about having sufficient food to survive, according to a study presented at the American Diabetes Association’s 75th Scientific Sessions. The findings suggest that food insecurity should be a factor considered in overall diabetes management.

Logo – http://photos.prnewswire.com/prnh/20141105/156803LOGO

Approximately 24 percent of Latino households in the U.S. were food insecure in 2013, compared to 14 percent for Americans overall, according to the U.S. Department of Agriculture. A 2012 study published in the journal Diabetes Spectrum found that diabetes risk was roughly 2.5 percent higher in households reporting food insecurity.

Researchers at the Emory School of Medicine/Grady Hospital in Atlanta, Georgia decided to explore the impact of food insecurity on diabetes management after hearing from patients that they could not afford to buy healthy foods, such as fresh vegetables. To measure food insecurity, they asked whether patients had been worried about having enough food to eat at any point in the past 30 days. They also developed a tool based on the plate method to assess the amount of vegetables patients were eating during their main meal each day (full plate, one-half, one-third of a plate, one-fourth of a plate, or no vegetables). Lastly, the Emory research team also measured and analyzed differences in A1C (a three-month measure of glycemic control) of the food insecure and food secure patients.

“We found that those patients who were food insecure had higher A1C levels and ate fewer vegetables,” said Britt Rotberg, MS, RDN, LD, CDE, BC-ADM, Assistant Director of the Emory Diabetes Education Training Academy, Emory Latino Diabetes Education Program at the Emory School of Medicine. “These findings underscore the importance of individualized diabetes management, and the need to take into account not only patients’ socioeconomic status, but food availability, when discussing diabetes self-management. We should find new ways to help our food insecure patients obtain nutritionally adequate foods.”

The study found that those who were food insecure had average A1C levels of 9.9 percent, compared to 7.6 percent for those who were food secure. It also showed that those who were food insecure ate fewer vegetables than those who were food secure. When looking at patients who consumed more than one-third of a plate of non-starchy vegetables at their main meal, 62 percent were food secure compared to 38 percent who were food insecure.

Rotberg said there was no significant difference in body mass index (BMI) between the two groups, suggesting that “both groups may consume comparable calories per the individuals’ requirements, but with a difference in nutrient density potentially determining the difference in glycemic control.”

The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (800-342-2383) or visit diabetes.org. Information from both these sources is available in English and Spanish.


Are Offspring of Obese Moms Pre-Programmed for Obesity and Metabolic Disease?

0





Are Offspring of Obese Moms Pre-Programmed for Obesity and Metabolic Disease?

Umbilical Cord Stem Cells Offer Clues to Mechanism by Which Obesity and Diabetes are Passed to Next Generation


BOSTON, June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — The evidence is clear that the children of obese parents are prone to obesity themselves, placing them at higher risk for type 2 diabetes, but how and why this occurs remains under investigation. A study being presented at the American Diabetes Association’s 75th Scientific Sessions found evidence suggesting that the in utero environment in obese mothers may program a child’s cells to accumulate extra fat or develop differences in metabolism that could lead to insulin resistance.

Logo – http://photos.prnewswire.com/prnh/20141105/156803LOGO

“One of the questions that needs to be explored is how children of obese mothers may be at risk for becoming obese as a result of factors that occur even before they are born,” said Kristen E. Boyle, PhD, assistant professor at the University of Colorado School of Medicine. “Our study looked at the mechanism by which children may be preprogrammed for increased obesity risk, because of changes occurring in utero.”

Boyle and her team took stem cells from donated umbilical cords of the babies of normal-weight and obese mothers and grew them into fat and muscle cells in the lab. They found 30 percent higher fat content in both types of cells in the offspring of mothers who were obese at their first prenatal visit, compared to the cells of offspring of normal-weight moms. They are continuing to evaluate the data to determine if these cells likewise show evidence of altered metabolism.

“At this point, because this is fairly preliminary, we don’t know how these differences in cells grown in the lab correspond to the physiology of these children after birth,” Boyle said. “But it’s clear that there is an inherent propensity toward more fat content in the cells from offspring of obese moms, in culture. We also know that the fat accumulation in these cells corresponded to the baby’s fat mass at birth. The next step is to follow these offspring to see if there is a lasting change into adulthood.”

Boyle and her team expect to soon have additional information on how the cells use fat for energy production and whether this contributes to the greater fat accumulation in the cells from the offspring of obese mothers. They are continuing to conduct a full, metabolic assessment of the cells to determine whether the cells in the offspring of obese moms display inflammation, insulin resistance or other metabolic differences.

The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (800-342-2383) or visit diabetes.org. Information from both these sources is available in English and Spanish.


Denny’s “Kids Eat Free” Tuesdays Just Got A Whole Lot More Fun

0
Denny's Kids Eat Free





Denny’s “Kids Eat Free” Tuesdays Just Got A Whole Lot More Fun

America’s Diner partners with DreamWorks Animation to offer Spanish-language interactive kids menu and activity book featuring the adored
Penguins of Madagascar characters


SPARTANBURG, S.C., June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — Denny’s, America’s family diner, has teamed up with DreamWorks Animation to promote their “Kids Eat Free” program. “Kid’s Eat Free,” available nationwide on Tuesdays from 4pm-10pm, allow for parents and kids to enjoy an affordable dining-out experience on Tuesday nights, and select from Denny’s many kid-friendly options.

Eating together as a family is central to Latinos and serving their children tasty and healthy food straight from the kitchen is paramount to Latina moms. Denny’s “Kids Eat Free” DreamWorks menu includes breakfast, lunch and dinner plates and nourishing side options to balance the meal – fresh fruits, vegetables, juices, salad, yogurt and milk.

To enhance the dining experience, the kid’s activity book is chockfull of themed puzzles and interactive games featuring DreamWorks character favorites. And, parents can download the free DreamWorks COLOR App to watch their children’s color drawings come to 3D life, enjoy family-friendly activities, and view original movie content and more.

In addition, families have the chance to win great DreamWorks prizes by visiting the Spanish-language Denny’s Latino Facebook Page for a limited time only: June 10 – June 16 and sharing their personal stories/memories of dining as a family at Denny’s.

“Denny’s is a family-focused diner because, like our Latino clientele, we know the importance of sharing a meal together as a family. Our Spanish-language kids menu offers made-to-order meals straight from the kitchen, and the widely popular DreamWorks characters,” said John Dillon, @DillonJohnW, senior vice president and chief marketing officer of Denny’s Corporation. “We invite families to take the evening off from cooking, and join us at our table during ‘Kids Eat Free’ on Tuesdays. The little ones will enjoy their yummy meal while interacting with their favorite Penguins of Madagascar characters found throughout the new menu and activity book.”

For more information about Denny’s new DreamWorks kids menu or to find a restaurant near you, please visit www.dennys.com. To download the DreamWorks COLOR App, please visit www.dreamworkscolor.com.

About Denny’s Corp.
Denny’s is one of America’s largest full-service family restaurant chains, currently operating 1,700 franchised, licensed and company-owned restaurants across the United States, Canada, Chile, Costa Rica, Curacao, Dominican Republic, El Salvador, Guam, Honduras, Mexico, Puerto Rico and New Zealand. For further information on Denny’s, including news releases, please visit the Denny’s website at www.dennys.com or the brand’s social channels via Facebook, Twitter, Tumblr, Pinterest, Instagram or YouTube.

NOTE TO EDITORS: Multimedia assets are available at:: http://hispanicprwire.com/en/multimedia/


Vaccines Needed To Keep Serious Diseases From Returning

0






NEW YORK, June 9, 2015 /PRNewswire-HISPANIC PR WIRE/ — The outbreak of measles that began in California and spread to several other states earlier this year demonstrated that vaccine-preventable diseases are not a thing of the past, as many Americans seem to believe.  Some potentially disabling and fatal infectious diseases are making a comeback, and vaccines are critically important to preventing these once-common childhood diseases from threatening the public’s health again. 

Logo – http://photos.prnewswire.com/prnh/20150409/197662LOGO

“These recent outbreaks teach us that these diseases are still around and can show up anywhere,” said Mark H. Sawyer, MD, professor, Clinical Pediatrics, Division of Infectious Diseases, University of California, San Diego School of Medicine-Rady Children’s Hospital. “Making sure everyone is immunized can prevent future widespread outbreaks and create herd immunity that will protect vulnerable people who can’t get the vaccine because their immune systems are suppressed or because they are too young to be immunized.”

Even pregnant women should be immunized, according to Sonja Rasmussen, MD, MS, Editor-in-Chief, Morbidity and Mortality Weekly Report (MMWR), U.S. Centers for Disease Control and Prevention. “A pregnant woman should get all the recommended vaccinations, including a pertussis booster and an annual flu shot.  Being immunized not only protects her health, it protects her baby from the day it’s born,” Dr. Rasmussen said.

The two leading experts on vaccines made their comments and presented their latest research at a luncheon sponsored by the March of Dimes.  The March of Dimes funded the development of the polio vaccine and encourages parents to keep their children and the community of children safe by following the schedule of vaccination recommended by the American Academy of Pediatrics.

The U.S. Centers for Disease Control and Prevention (CDC) calls vaccines one of the 10 greatest health achievements of the 20th century. Yet cases of measles and whooping cough are increasing because of declining immunization rates.

“Vaccines defeated diseases like polio, measles, pertussis and just recently rubella, (German measles),” says Edward R. B. McCabe, MD, PhD, March of Dimes Chief Medical Officer. “Those vaccines were successful because of consistent, long-term efforts. This recent lapse in our vigilance and commitment allowed these deadly diseases to return and spread. The March of Dimes remains a staunch advocate for vaccination of all children and pregnant women in accordance with the CDC’s recommendations.”

With chapters nationwide and its premier event, March for Babies, the March of Dimes works to improve the health of babies by preventing birth defects, premature birth and infant mortality. For the latest resources and information, visit marchofdimes.com or nacersano.org. Find us on Facebook and follow us on Twitter.


Primary Endpoint met for Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

0





Primary Endpoint met for Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)

TECOS Results presented at the 75th Scientific Sessions of the American Diabetes Association convention, Boston, USA

Oxford University and Duke Clinical Research Institute News Release


ALEXANDRIA, Va., June 8, 2015 /PRNewswire-HISPANIC PR WIRE/ — Treatment with sitagliptin, a DPP-4 inhibitor, versus placebo for median 3 years in 14,671 patients with type 2 diabetes (T2DM) and established cardiovascular (CV) disease showed non-inferiority for the primary composite cardiovascular endpoint of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS), and no increase in hospitalization for heart failure in the sitagliptin group.

Logo – http://photos.prnewswire.com/prnh/20141105/156803LOGO

Researchers at the University of Oxford Diabetes Trials Unit (DTU) and the Duke Clinical Research Institute (DCRI) have found that among patients with T2DM and established CV disease, addition of sitagliptin to usual care did not impact on the risk for major adverse CV events, hospitalization for heart failure or adverse events. Concerns about possible links between incretin-based therapies and effects on the pancreas have been raised. In TECOS, acute pancreatitis and pancreatic cancer were uncommon and not statistically significant different between groups. Numerically, in the sitagliptin group there were more patients with acute pancreatitis and fewer patients with pancreatic cancer than in the placebo group.

Professor Rury Holman of Oxford University, Joint Chair of the study, commented ‘TECOS provides reassurance that sitagliptin may be used safely to improve blood glucose levels in a diverse group of T2DM patients at high cardiovascular risk without impacting on rates of cardiovascular complications or heart failure.’

Professor Eric Peterson, DCRI Executive Director at Duke University and Joint Chair of the study, stated: ‘TECOS is an excellent example of academic and industry collaborative research.’

TECOS was designed, run, and analyzed independently by DTU and DCRI, in an academic collaboration with Merck & Co., Inc., Kenilworth, NJ, USA, (known as MSD outside the United States and Canada), who sponsored and funded the study.

The TECOS results will be published online in the New England Journal of Medicine on Monday 8th June 2015. A slide set reflecting the data presented at the American Diabetes Association will be available to download from http://www.dtu.ox.ac.uk/TECOS/ after 6.30pm EDT (11.30pm BST) the same day.

Notes for Editors

For more information please contact:

The News and Information Office, University of Oxford, (+44) 1865 270046. [email protected].  

Susan Landis, Strategic Communications. [email protected]. (+1) 919-668-5759.

*The American Diabetes Association is holding its 75th Annual Scientific Sessions in Boston, USA, on June 5 – 9 2015. See http://scientificsessions.diabetes.org for more information. 

*The American Diabetes Association is leading the fight to Stop Diabetes® and its deadly consequences and fighting for those affected by diabetes. The Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes. For the past 75 years, our mission has been to prevent and cure diabetes and to improve the lives of all people affected by diabetes. For more information please call the American Diabetes Association at 1-800-DIABETES (800-342-2383) or visit diabetes.org. Information from both these sources is available in English and Spanish.

*Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) was an event-driven trial conducted in adults with type 2 diabetes and a history of cardiovascular (CV) disease in a usual care setting. The trial was designed to assess the CV safety of long-term treatment with sitagliptin (JANUVIA®) when added to existing therapy compared with placebo. The primary composite CV outcome was the time to the first confirmed event of CV-related death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. TECOS enrolled 14,724 participants from 38 countries between December 2008 and July 2012 with a median follow-up of three years. See TECOS-study.org

*Funding was provided by Merck & Co., Inc., Kenilworth, NJ, USA, (known as MSD outside the United States and Canada) who market sitagliptin (JANUVIA®). See www.merck.com

*The Duke Clinical Research Institute (DCRI) is the world’s largest academic clinical research organization. DCRI research spans multiple disciplines, from pediatrics to geriatrics, primary care to subspecialty medicine, and genomics to proteomics. The DCRI is also home to the Duke Databank for Cardiovascular Diseases, the largest and oldest institutional cardiovascular database in the world, which continues to inform clinical decision-making 40 years after its founding. The DCRI has conducted studies at more than 37,000 sites in 65 countries; completed more than 970 phase I-IV clinical trials, studies of patient outcomes and analyses of comparative effectiveness; managed national patient registries; enrolled more than 1.2 million patients in DCRI studies; and published more than 9,000 papers in peer-reviewed journals.

*The Diabetes Trials Unit (DTU) is a fully registered UKCRC Clinical Trials Unit and a founder member of Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM). It is one of only a handful of Academic Research Organisations (AROs) worldwide that specialise in performing diabetes-related mega trials. The DTU designs, runs and analyses large-scale Phase III/IV interventional clinical outcome trials nationally and internationally, often in collaboration with other AROs and pharmaceutical companies. Currently the DTU is undertaking 4 large-scale cardiovascular outcome trials in 40 countries recruiting more than 48,000 patients. See www.dtu.ox.ac.uk.

*OCDEM (Oxford Centre for Diabetes, Endocrinology and Metabolism) is a pioneering centre at Oxford University which combines clinical care, research and education in diabetes, endocrine and metabolic diseases. By promoting world-class research, it aims to enhance understanding of these diseases and to accelerate the search for new treatments and cures. See www.ocdem.ox.ac.uk